Ovarian Cancer – BJ Rimel, MD, and Robert Figlin, MD, discuss recent studies and FDA approvals in ovarian cancer

Ovarian Cancer – BJ Rimel, MD, and Robert Figlin, MD, discuss recent studies and FDA approvals in ovarian cancer

Thursday May 7, 2020

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and BJ Rimel, MD, Assistant Professor, Obstetrics and Gynecology, Cedars-Sinai Medical Center, discuss recent clinical studies in ovarian cancer and how recent developments are impacting the way ovarian cancer patients are treated.

Featured Videos

Charles Rudin, MD, PhD, discusses the Keynote-604 study and the role of Keytruda in ES-SCLC

Charles Rudin, MD, PhD, shares outcomes of the Keynote 604 study investigating the combination of Keytruda and chemotherapy in ES-small lung cancer patients

Karen Lu, MD, discusses how PARP inhibitors have changed the management of advanced ovarian cancer